IP lawyer: Amped-up protection on the cards for recombinant DNA products

Australian patent authorities continue to wrestle with the treatment of gene-related inventions. A new ruling may extend the life of patents covering medicines made with recombinant DNA technology

Enter your details below to log into your account.

Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.

Twitter

18 Sep 2021

@IAM_Alerts IP and licensing failures are holding back adoption of new video codecs, says Micky Minhas in this week’s Saturday… https://t.co/9mEmAimuL4 Read more

17 Sep 2021

@IAM_Alerts RT @AMorrisReports: Recent #FTC announcement beefing up investigative powers & targeting alleged #IP abuses signals another Biden administr… Read more

17 Sep 2021

@IAM_Alerts RT @AMorrisReports: This is blowing my mind. 6G??? Sign me up! https://t.co/yM05XY1dDf @IAM_Alerts https://t.co/0iCAh22EQs Read more

17 Sep 2021

@IAM_Alerts $300 million Bausch Health settlement demonstrates the huge sums at stake in reverse payment disputes:… https://t.co/fsfG5fEp4x Read more

IP lawyer: Amped-up protection on the cards for recombinant DNA products

Returning user?

Want to read more?

TAGS

Twitter